The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis

1999 JAMA 1,960 citations

Abstract

Our data indicate that the use of summary scores to identify trials of high quality is problematic. Relevant methodological aspects should be assessed individually and their influence on effect sizes explored.

Keywords

MedicineMeta-analysisBlindingClinical trialRelative riskConfidence intervalLow molecular weight heparinDeep veinThrombosisInternal medicine

Affiliated Institutions

Related Publications

Empirical Evidence of Bias

<h3>Objective.</h3> —To determine if inadequate approaches to randomized controlled trial design and execution are associated with evidence of bias in estimating treatment effec...

1995 JAMA 5475 citations

Publication Info

Year
1999
Type
article
Volume
282
Issue
11
Pages
1054-1054
Citations
1960
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1960
OpenAlex

Cite This

Peter Jüni (1999). The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis. JAMA , 282 (11) , 1054-1054. https://doi.org/10.1001/jama.282.11.1054

Identifiers

DOI
10.1001/jama.282.11.1054